Last reviewed · How we verify
influenza vaccine(BK01 adjuvnat) — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
influenza vaccine(BK01 adjuvnat) (influenza vaccine(BK01 adjuvnat)) — Changchun BCHT Biotechnology Co..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| influenza vaccine(BK01 adjuvnat) TARGET | influenza vaccine(BK01 adjuvnat) | Changchun BCHT Biotechnology Co. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- influenza vaccine(BK01 adjuvnat) CI watch — RSS
- influenza vaccine(BK01 adjuvnat) CI watch — Atom
- influenza vaccine(BK01 adjuvnat) CI watch — JSON
- influenza vaccine(BK01 adjuvnat) alone — RSS
Cite this brief
Drug Landscape (2026). influenza vaccine(BK01 adjuvnat) — Competitive Intelligence Brief. https://druglandscape.com/ci/influenza-vaccine-bk01-adjuvnat. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab